UBS downgrades Merck to Neutral, cuts price target to $150
UBS downgrades MRK to Neutral from Buy and sets a $150.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.